Abstract

The effects of pharmacological manipulations of the two subtypes of central a-adrenergic receptors, designated α1 and α2, respectively, on the secretion of TSH and GH were tested in conscious unrestrained male rats. Intraventricular (ivt) administration of the α1-receptor agonist, methoxamine, induced a rapid and dose-related lowering of the plasma levels of both hormones, which was antagonized by systemic administration of the α1 antagonist, prazosin. Intraventricular administration of phenylephrine, another α1 agonist, also depressed plasma levels of both hormones. In contrast, the administration of relatively small doses (50 or 12.5 μg/kg, iv) of the α2 agonist, clonidine, induced large, dose-related secretory surges of both TSH and GH. The TSH/GH-stimulating effect of clonidine was inhibited in a dose-related fashion by the Α2 antagonist, yohimbine. Prazosin was ineffective against the TSH-stimulating effect, but it partially suppressed the GH secretory response, which may indicate involvement of a mi...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.